Global Mobile Cardiac Telemetry Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Mobile Cardiac Telemetry Device Market is presumed to reach the market size of nearly USD 2456.69 MN by 2030 from USD 950.07 MN in 2022 with a CAGR of 12.6% under the study period 2023 - 2030.

A Mobile Cardiac Telemetry or MCT device is a small, wearable device that continuously monitors a patient's heart rhythm and other cardiac parameters. It is used to diagnose and monitor cardiac arrhythmias, such as atrial fibrillation, which may cause symptoms such as palpitations, dizziness, and shortness of breath. The device is typically worn for a period of up to 30 days, during which time it records the patient's heart rhythm and other cardiac data. The device may also have a built-in event monitor that allows the patient to record any symptoms they experience during the monitoring period. The data collected by the MCT device is transmitted wirelessly to a monitoring center, where it is analyzed by trained professionals who can quickly identify any abnormalities in the patient's heart rhythm.

Market Dynamics:

The increasing incidence of cardiovascular diseases such as arrhythmias, atrial fibrillation, and heart failure is driving the demand for Mobile Cardiac Telemetry Devices. The American Heart Association states that cardiovascular disease accounts for over 17 million deaths annually. This supports the availability of a wide MCT device market. The development of new and advanced Mobile Cardiac Telemetry Devices with features such as real-time monitoring, wireless connectivity, and automated analysis is driving the growth of the market. These devices are more convenient and accurate than traditional cardiac monitoring methods, making them popular among patients and healthcare providers. The adoption of remote patient monitoring (RPM) is increasing rapidly, driven by the need to reduce healthcare costs, improve patient outcomes, and provide more convenient care. Mobile Cardiac Telemetry Devices are an important part of RPM, as they allow healthcare providers to monitor patients' cardiac health remotely. The demand for personalized medicine is increasing as healthcare providers look for ways to tailor treatments to individual patients. Mobile Cardiac Telemetry Devices provide detailed information about patients' cardiac health, which can be used to develop personalized treatment plans.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mobile cardiac telemetry device. The growth and trends of mobile cardiac telemetry device industry provide a holistic approach to this study.

Market Segmentation:

This section of the mobile cardiac telemetry device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Lead-Based
Patch-Based

By Disease Indication

Angina Pectoris
Atherosclerosis
Heart Failure
Others

By End-User

Hospitals
Specialty Clinics
Diagnostic Centers
Home Care Settings
Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Mobile Cardiac Telemetry Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mobile cardiac telemetry device market include BioTelemetry Inc., ScottCare, Biotricity Inc., Welch Allyn, Applied Cardiac Systems Inc., Medicomp Inc., Preventice Solutions, Telerhythmics LLC, Zoll Medical Corporation, iRhythm Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR112110935

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . MOBILE CARDIAC TELEMETRY DEVICE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Disease Indication
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET ANALYSIS BY APPLICATION

5.1 Overview by Application
5.2 Historical and Forecast Data
5.3 Analysis by Application
5.4 Lead-based Historic and Forecast Sales by Regions
5.5 Patch-based Historic and Forecast Sales by Regions

6 . GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET ANALYSIS BY DISEASE INDICATION

6.1 Overview by Disease Indication
6.2 Historical and Forecast Data
6.3 Analysis by Disease Indication
6.4 Angina Pectoris Historic and Forecast Sales by Regions
6.5 Atherosclerosis Historic and Forecast Sales by Regions
6.6 Heart Failure Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Specialty Clinics Historic and Forecast Sales by Regions
7.6 Diagnostic Centers Historic and Forecast Sales by Regions
7.7 Home Care Settings Historic and Forecast Sales by Regions
7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE MOBILE CARDIAC TELEMETRY DEVICE COMPANIES

9.1. Mobile Cardiac Telemetry Device Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF MOBILE CARDIAC TELEMETRY DEVICE INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. BioTelemetry Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. ScottCare
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Biotricity Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Welch Allyn
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Applied Cardiac Systems Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Medicomp Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Preventice Solutions
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Telerhythmics LLC
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Zoll Medical Corporation
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. iRhythm Technologies Inc.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies